Africa: Johnson & Johnson Confirms Intent Not to Enforce Patents for SIRTURO® (bedaquiline) for the Treatment of Multidrug-Resistant Tuberculosis in 134 Low- and Middle-Income Countries
Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: ...
